Fangjun Chen

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Corrigendum to "Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer" [Cell. Immunol. 365 (2021) 104376].

Corrigendum to "Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer" [Cell. Immunol. 365 (2021) 104376].

Journal: Cellular immunology
Published: July 07, 2026

Clinicopathological and molecular characteristics of primary pulmonary choriocarcinoma: a case report and systematic review.

Clinicopathological and molecular characteristics of primary pulmonary choriocarcinoma: a case report and systematic review.

Journal: Frontiers in oncology
Published: May 18, 2026

Clinical application and institutional governance of foods for special medical purposes in medical institutions of eastern coastal China: a cross-sectional study.

Clinical application and institutional governance of foods for special medical purposes in medical institutions of eastern coastal China: a cross-sectional study.

Journal: Frontiers in nutrition
Published: December 26, 2025

Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design.

Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design.

Journal: Human vaccines & immunotherapeutics
Published: January 12, 2024

Individualised adjuvant immunotherapy with neoantigen-reactive T cells for gastric signet-ring cell carcinoma.

Individualised adjuvant immunotherapy with neoantigen-reactive T cells for gastric signet-ring cell carcinoma.

Journal: Clinical & translational immunology
Published: November 16, 2022

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High-Risk Gastric/Gastroesophageal Junction Cancer.

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High-Risk Gastric/Gastroesophageal Junction Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 05, 2022

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer.

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer.

Journal: Cancers
Published: May 01, 2022

Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report.

Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report.

Journal: Frontiers in immunology
Published: March 24, 2021

Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma.

Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma.

Journal: Frontiers in oncology
Published: March 11, 2021

Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer.

Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer.

Journal: Cellular immunology
Published: February 22, 2021

Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer.

Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer.

Journal: OncoTargets and therapy
Published: October 05, 2019

Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression.

Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression.

Journal: Oncotarget
Published: April 23, 2019
Showing 1-12 of 27

Last Updated: 09/26/2026